1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TRAVERE THERAPEUTICS INC
Travere Therapeutics Inc XNAS: TVTX

Travere Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...

Read More
23.47 -1.53 (-6.12%)
New 52W High in past week
2.9M
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
8.7 / 100
Momentum Score
Technically Moderately Bullish
61.5 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
36
1Yr Price target upside is 53%
13 analysts

15

S

11

W

2

O

0

T

SWOT Analysis

Travere Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..